In addition, GSEA analysis revealed that genes enriched in the tumor suppressor p53 pathway were activated in HCC cells following iberverin exposure, which could also directly affect MMP (Noutsopoulos et al., 2010). Here, TP53 is linked to hepatocellular carcinoma.